Peer Reviewed Article
Published:
April 1, 2018

Assessing Risk Factors, Presentation, and Management of Portomesenteric Vein Thrombosis After Sleeve Gastrectomy: A Multicenter Case-Control Study

Rena C. Moon, Muhammad Ghanem, Andre F. Teixeira, Nestor de la Cruz-Muñoz, Michael K. Young, Patrick Domkowski, John Radecke, Scott G. Boyce, Raul Rosenthal, Emanuele Lo Menzo, David G. Blanco, Diego R. Funes, Muhammad A. Jawad

Assessing Risk Factors, Presentation, and Management of Portomesenteric Vein Thrombosis After Sleeve Gastrectomy: A Multicenter Case-Control Study — Surgery for Obesity and Related Diseases (SOARD), 2018
Key Takeaways
  • Portomesenteric vein thrombosis is one of the rarest but most serious complications after sleeve gastrectomy. This national multicenter study pooled data across programs, including Dr. de la Cruz-Muñoz's, to better understand risk and treatment.
  • The study identified specific risk factors, allowing surgeons to take extra precautions in higher-risk patients.
  • PMVT occurs in fewer than 1 in 100 patients, but early recognition is critical; the study characterized typical symptoms and timeline.
  • The multicenter design was essential since PMVT is too rare for a single hospital to study alone.
  • This study is part of a broader body of work on complication prevention and patient safety in bariatric surgery.
  • For patients considering sleeve gastrectomy, this study shows ongoing efforts to study and prevent even rare complications.
Abstract/Summary

This multicenter case-control study published in SOARD assessed the risk factors, clinical presentation, and management of portomesenteric vein thrombosis (PMVT) following laparoscopic sleeve gastrectomy. PMVT is a rare but potentially life-threatening complication in which blood clots form in the portal or mesenteric veins. The study pooled data from multiple bariatric surgery centers to identify risk factors, characterize clinical presentation, and evaluate management strategies. Dr. de la Cruz-Muñoz is a co-author, contributing cases from the University of Miami bariatric surgery program.

In-Depth Review

Why This Study Was Needed

Portomesenteric vein thrombosis (PMVT) is a blood clot in the veins that drain the intestines and spleen into the liver. It is rare after sleeve gastrectomy, but when it happens it can cut off blood flow to the bowel. Because it is rare, single programs see too few cases to learn who is at risk, how it presents and how best to treat it. This multicenter study pooled the experience of five US bariatric centers, including Dr. de la Cruz-Muñoz’s.

How the Study Was Done

Investigators reviewed 5,538 sleeve gastrectomies performed between 2008 and 2016 at five centers. Each of the 11 patients who developed PMVT was matched with three controls of similar age, sex, BMI and center, allowing a comparison of risk factors.

What the Study Found

  • PMVT occurred in 11 of 5,538 patients, about 0.2%.
  • A personal history of cancer and type 2 diabetes were the two independent risk factors.
  • Symptoms began on average 19 days after surgery (range 8 to 62 days), usually after discharge.
  • All but one patient presented with abdominal pain after bariatric surgery; others had nausea and vomiting, poor appetite, diarrhea or dehydration. White blood cell count was elevated in less than half.
  • CT scan made the diagnosis in every case.
  • All patients were treated with anticoagulation, most often a heparin drip; one required reoperation. No patients died.

What This Means for Patients

PMVT is uncommon, and with early diagnosis and blood thinners it is very treatable. The key is recognizing it: steadily worsening abdominal pain, especially with dehydration, in the first two months after a sleeve should prompt a call to your surgeon and usually a CT scan. Staying well hydrated after surgery (see our Hydration Guide) and walking early are simple protective steps. Patients with a history of cancer or diabetes may warrant extended blood-thinner prevention after surgery, in line with the ASMBS position statement on VTE prophylaxis. Learn more in our complete guide to the gastric sleeve and our article on nausea and vomiting after surgery: when to call.

Clinical Pearls

  • Incidence of PMVT after sleeve gastrectomy was about 0.2%.
  • Prior malignancy and type 2 diabetes independently increased risk.
  • Typical presentation is increasing abdominal pain about three weeks after surgery, often with dehydration.
  • CT with contrast is diagnostic; anticoagulation is first-line treatment, and surgery is rarely needed.

Strengths and Limitations

Pooling five centers created one of the larger reported series of this rare complication, and the matched case-control design helps isolate risk factors. With only 11 cases, the risk estimates have very wide confidence intervals, and the retrospective design depends on complete records and imaging practices that varied between centers.

Expert Commentary

PMVT is one of those complications every sleeve surgeon must keep in mind, because the patient often comes back weeks later with pain that can look like dehydration or a simple stomach upset. This study gave us a clearer picture of who is at risk and confirmed that, caught early, it responds well to anticoagulation.

For my patients, the message is simple: worsening belly pain in the first two months after a sleeve is always worth a phone call.

— Dr. Nestor de la Cruz-Muñoz

Moon RC, Ghanem M, Teixeira AF, De La Cruz-Muñoz N, Young MK, Domkowski P, Radecke J, Boyce SG, Rosenthal R, Menzo EL, Blanco DG, Funes DR, Jawad MA. Assessing Risk Factors, Presentation, and Management of Portomesenteric Vein Thrombosis After Sleeve Gastrectomy: A Multicenter Case-Control Study. Surgery for Obesity and Related Diseases. 2018;14(4):478-483. doi:10.1016/j.soard.2017.10.013.

Book Now
Close-up of a stethoscope, clipboard, and pen on a white surface, suggesting a medical or healthcare setting.

Contact Details

Black cross or x symbol on a transparent or white background, commonly used as a close button or cancel icon.